Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in ischemic stroke investigators.

L.J. Kappelle

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in ischemic stroke investigators.

Translated title of the contribution: Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in ischemic stroke investigators.

L.J. Kappelle

Neurology & Neurosurgery

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in ischemic stroke investigators.
Original language	Undefined/Unknown
Pages (from-to)	601-609
Number of pages	9
Journal	Stroke
Volume	31
Publication status	Published - 2000

Cite this

@article{ed91f8a420304d3e861d4ff7b74598fb,

title = "Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in ischemic stroke investigators.",

author = "L.J. Kappelle",

year = "2000",

language = "Undefined/Unknown",

volume = "31",

pages = "601--609",

journal = "Stroke",

issn = "0039-2499",

publisher = "Wolters Kluwer Health",

}